Trials / Unknown
UnknownNCT06250127
The Effectiveness of Modified 3D Printed Customized Facemask Appliance for Treatment of Class III Malocclusion
The Effectiveness of Modified 3D Printed Customized Facemask Appliance for Treatment of Class III Malocclusion: A Randomized Clinical Trial
- Status
- Unknown
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 34 (estimated)
- Sponsor
- University of Baghdad · Academic / Other
- Sex
- All
- Age
- 6 Years – 12 Years
- Healthy volunteers
- Accepted
Summary
A randomized clinical trial to introduce a modified 3D printed customized maxillary protraction facemask and evaluate its efficacy in comparison with the conventional maxillary protraction facemask therapy in correction of Class III malocclusion of young patients
Detailed description
It is a multicenter randomized clinical trial with two parallel arms. The patients will be randomly divided into two groups, group one: conventional facemask appliance will be used while group two, the modified facemask appliances. Lateral cephalometric x-ray, Study models, photographs, and patient questionnaire will be taken before starting the treatment (T0) and at the end of treatment (T1). The effectiveness of the two appliances will be assessed and measured comparing patient's records before and after treatment.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DEVICE | Modified 3D printed facemask | modified 3D printed customized maxillary protraction facemask will be used for growing patients who have Cl. III malocclusion, hyrax expansion appliance and applying an elastic force of 300-500 gram per side for 12-14 hours per day. Treatment time 9 months. |
| DEVICE | Conventional facemask appliance | Conventional facemask appliance will be used for growing patients who have Cl. III malocclusion, hyrax expansion appliance and applying an elastic force of 300-500 gram per side for 12-14 hours per day. Treatment time 9 months. |
Timeline
- Start date
- 2022-12-01
- Primary completion
- 2024-06-01
- Completion
- 2024-08-01
- First posted
- 2024-02-08
- Last updated
- 2024-02-12
Locations
2 sites across 1 country: Iraq
Source: ClinicalTrials.gov record NCT06250127. Inclusion in this directory is not an endorsement.